Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study
Human Psychopharmacology: Clinical and Experimental · 2025
DOI: 10.1002/hup.70002 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2025. Verfasst von Blair Aitken und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Cognition, Methylphenidate, Psychomotor Performance. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To examine the effect of a low dose (10 mg) of methylphenidate on cognitive performance, visuospatial working memory (VSWM) and gaze behaviour capabilities in healthy adults.
Methods
This randomised, double‐blind, placebo‐controlled and crossover study examined the effects of 10 mg methylphenidate on cognitive performance, VSWM and gaze behaviour. Fixation duration and rate, gaze transition entropy, and stationary gaze entropy were used to quantify visual scanning efficiency in 25 healthy adults (36% female, mean ± SD age = 33.5 ± 7.8 years, BMI = 24.1 ± 2.9 kg/m 2 ). Attention, memory, and reaction time were assessed using the E‐CogPro test battery.
Results
Methylphenidate significantly enhanced performance in numeric working memory tasks, reflected by reduced errors and increased accuracy relative to placebo. No significant changes were observed in other cognitive or visual scanning metrics.
Conclusions
A low dose of methylphenidate improves limited domains of psychomotor speed and accuracy but does not affect visual scanning efficiency. This suggests limited usefulness as a general pro‐cognitive aid and raises the possibility of a lower threshold of effect for measurable psychostimulant‐induced changes to visual scanning behaviour. Further research is needed to explore these potential dose‐response relationships and effects across diverse populations. Trial Registration ACTRN12620000499987
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia.
- Institute for Breathing and Sleep (IBAS), Austin Health, Heidelberg, Australia.
- Human Factors, Seeing Machines, Fyshwick, Australia.
ORCID-Profile: Amie C Hayley
Zitieren
APA
Aitken, B., Downey, L. A., Rose, S., Manning, B., Arkell, T. R., Shiferaw, B., & Hayley, A. C. (2025). Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.70002
Vancouver
Aitken B, Downey LA, Rose S, Manning B, Arkell TR, Shiferaw B, et al. Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study. Human Psychopharmacology: Clinical and Experimental. 2025. doi:10.1002/hup.70002
BibTeX
@article{Aitken2025,
author = {Aitken, Blair and Downey, Luke A and Rose, Serah and Manning, Brooke and Arkell, Thomas R and Shiferaw, Brook and Hayley, Amie C},
title = {Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2025},
doi = {10.1002/hup.70002}
}
EUVIMED